Cost-effectiveness analysis of abciximab: a Canadian hospital perspective (Q48027994)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 1998

edit

Language	Label	Description	Also known as
English	Cost-effectiveness analysis of abciximab: a Canadian hospital perspective	scientific article published in May 1998

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

title

Cost-effectiveness analysis of abciximab: a Canadian hospital perspective (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

author name string

P J Zed

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

L Frighetto

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

R Sunderji

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

C A Marra

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

language of work or name

English

0 references

publication date

1 May 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

published in

Annals of Pharmacotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

page(s)

536-542

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

cites work

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Advances in coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous T

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

The generalisability of pharmacoeconomic studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Long-term outcome following successful reopening of abrupt closure after coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.17336

retrieved

21 January 2018

Identifiers

DOI

10.1345/APH.17336

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

PubMed publication ID

9606473

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9606473

retrieved

7 February 2018

reference URL

http://europepmc.org/abstract/MED/9606473

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48027994&oldid=2181937840"